Explanatory Statement
1. Authority
Section 13 of the Food Standards Australia New Zealand Act 1991 (the FSANZ Act) provides that the functions of Food Standards Australia New Zealand (the Authority) include the development of standards and variations of standards for inclusion in the Australia New Zealand Food Standards Code (the Code).
Division 1 of Part 3 of the FSANZ Act specifies that the Authority may accept applications for the development or variation of food regulatory measures, including standards. This Division also stipulates the procedure for considering an application for the development or variation of food regulatory measures.
FSANZ accepted Application A1061 which seeks to approve the use of a new enzyme processing aid, amylomaltase sourced from Bacillus amyloliquefaciens containing the gene for amylomaltase derived from Thermus thermophilus (for use to produce modified potato starch as an ingredient in food). The Authority considered the Application in accordance with Division 1 of Part 3 and has prepared a draft variation of a standard.
Following consideration by the COAG Legislative and Governance Forum on Food Regulation[1] (the Forum), section 92 of the FSANZ Act stipulates that the Authority must publish a notice about the standard or draft variation of a standard.
Section 94 of the FSANZ Act specifies that a standard, or a variation of a standard, in relation to which a notice is published under section 92 is a legislative instrument, but is not subject to parliamentary disallowance or sunsetting under the Legislative Instruments Act 2003.
2. Purpose and operation
Currently there is no permission in the Code for the use of amylomaltase sourced from genetically modified B. amyloliquefaciens as a processing aid.
The Authority has approved the draft variation to the Table to clause 17 of Standard 1.3.3 – Processing Aids, to permit the use of amylomaltase EC 2.4.1.25 sourced from B. amyloliquefaciens containing the T. thermophilus gene for amylomaltase.
3. Documents incorporated by reference
The variations to food regulatory measures do not incorporate any documents by reference.
4. Consultation
In accordance with the procedure in Division 1 of Part 3 of the FSANZ Act, the Authority’s consideration of Application A1061 has included one round of public consultation following an assessment and the preparation of a draft Standard. An Assessment Report (which included the draft Standard) was released for consultation on 31 October 2011 for a six-week consultation period.
A Regulation Impact Statement was not required because the proposed variation to Standard 1.3.3 is likely to have a minor impact on business and individuals.
5. Statement of compatibility with human rights
This instrument is exempt from the requirements for a statement of compatibility with human rights as it is a non-disallowable instrument under section 94 of the FSANZ Act.
6. Variation
Item [1] inserts an entry into the Table to clause 17 of Standard 1.3.3 to permit the use of amylomaltase from genetically modified B. amyloliquefaciens in the course of manufacture of any food sold in Australia and New Zealand provided the amylomaltase gene is derived from T. thermophilus.
[1] Previously known as the Australia and New Zealand Food Regulation Ministerial Council
Overview
The Food Standards Australia New Zealand Act 1991 (FSANZ Act) established Food Standards Australia New Zealand (FSANZ) to develop and maintain the Australia New Zealand Food Standards Code (the Code). Enacted by the Australian Parliament, the Act aims to ensure the safety and quality of the food supply across both countries. In response to Application A1061, FSANZ has prepared a draft variation to permit the use of a new enzyme processing aid, amylomaltase sourced from genetically modified Bacillus amyloliquefaciens containing the gene for amylomaltase derived from Thermus thermophilus, for producing modified potato starch as an ingredient in food. This variation was considered in line with the FSANZ Act's provisions and underwent public consultation. The Authority’s decision follows the approval of the draft variation by the COAG Legislative and Governance Forum on Food Regulation, with the proposed change to Standard 1.3.3—Processing Aids, enabling the use of this enzyme under specified conditions. This legislative instrument does not incorporate documents by reference and is exempt from a Statement of Compatibility with Human Rights as it is a non-disallowable instrument under section 94 of the FSANZ Act.
Scope and Application
The Act pertains to the regulation and development of food standards in Australia and New Zealand, overseen by Food Standards Australia New Zealand (FSANZ), as established under section 13 of the Food Standards Australia New Zealand Act 1991 (the FSANZ Act). The Act applies to the Authority and its procedures for accepting and considering applications for the development or variation of food regulatory measures, including standards. The scope of the Act extends to the publication of notices regarding standards or draft variations, as mandated by section 92 of the FSANZ Act, and the subsequent enactment of these standards or variations as legislative instruments under section 94, which are exempt from parliamentary disallowance or sunsetting. This legislation operates across the Commonwealth, encompassing both Australia and New Zealand, with its regulatory measures being applicable to the food industry and any entities involved in food manufacturing, ensuring that all food products meet the set safety and quality standards. The Act does not incorporate any documents by reference and, in the case of the proposed variation concerning amylomaltase, it was subject to a single round of public consultation as per the Act’s procedural requirements.
Key Provisions
The main operative sections of this legislation include sections 13, 92, and 94 of the Food Standards Australia New Zealand Act 1991 (FSANZ Act). Section 13 establishes the Authority's function in developing food standards and variations, while section 92 requires the Authority to publish a notice about a draft variation of a standard. Section 94, in turn, specifies that the draft variation of a standard is a legislative instrument, exempt from parliamentary disallowance or sunsetting. The legislation seeks to amend Standard 1.3.3 – Processing Aids, by inserting an entry that permits the use of amylomaltase from genetically modified B. amyloliquefaciens in food manufacturing. This variation is subject to acceptance by the COAG Legislative and Governance Forum on Food Regulation.
The obligations and requirements imposed by this legislation include the Authority's responsibility to consider applications for the development or variation of food regulatory measures, including standards. The Authority must also publish a notice about the standard or draft variation of a standard in accordance with section 92 of the FSANZ Act. Furthermore, the Authority is required to conduct public consultation as part of the consideration process for such applications. In this instance, the Authority carried out one round of public consultation following the assessment and preparation of the draft Standard.
The legislation does not explicitly outline any offences, penalties, or civil/criminal consequences for breach. However, it is important to note that the draft variation of a standard is a legislative instrument exempt from parliamentary disallowance or sunsetting under section 94 of the FSANZ Act. Therefore, any breach of the newly amended standard would be subject to the applicable laws and regulations governing food safety and standards in Australia and New Zealand. The Authority may also take enforcement action against entities found in violation of the amended standard.